ZANVASTRO
- Product NDC
- 71860-304
- Requested package NDC
- 71860-304-01
- 11-digit product format
- 718600304
- Labeler code
- 71860
- Product ID
- 71860-304_5b752db5-061f-8804-e063-6394a90aa4af
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- zilganersen
- Dosage form
- KIT
- Labeler
- Ionis Pharmaceuticals Inc.
- Application
- NDA220210
- Marketing category
- NDA
- Marketing start
- 2026-09-03
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ZANVASTRO
- Listing expiration
- 2027-12-31
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71860-304-01 | 71860030401 | 1 KIT in 1 CARTON (71860-304-01) * 21 mL in 1 VIAL, SINGLE-DOSE (71860-200-01) * 2.8 mL in 1 VIAL, SINGLE-DOSE (71860-104-01) | 1 kit | 2026-09-03 | No | No | Current |